Scarica l'app Stockscreener
24.44
6.86%
1.57
Dopo l'orario di chiusura:
24.28
-0.16
-0.65%
Precedente Chiudi:
$22.87
Aprire:
$22.83
Volume 24 ore:
432.77K
Relative Volume:
1.01
Capitalizzazione di mercato:
$1.33B
Reddito:
-
Utile/perdita netta:
$-102.09M
Rapporto P/E:
-23.28
EPS:
-1.05
Flusso di cassa netto:
$-108.72M
1 W Prestazione:
+16.99%
1M Prestazione:
+27.49%
6M Prestazione:
+158.48%
1 anno Prestazione:
+440.71%
Intervallo 1D:
$22.83
$24.58
Intervallo di 1 settimana:
$20.84
$25.40
Portata 52W:
$3.8001
$26.18
Dbv Technologies Adr Stock (DBVT) Company Profile
Nome
Dbv Technologies Adr
Settore
Industria
Telefono
33(0)155427878
Indirizzo
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Confronta DBVT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DBVT
Dbv Technologies Adr
|
24.44 | 1.24B | 0 | -102.09M | -108.72M | -1.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-12-03 | Iniziato | Guggenheim | Buy |
| 2025-05-29 | Ripresa | Goldman | Sell |
| 2023-01-04 | Aggiornamento | Societe Generale | Hold → Buy |
| 2022-12-16 | Downgrade | Goldman | Neutral → Sell |
| 2022-05-10 | Downgrade | Goldman | Buy → Neutral |
| 2021-09-14 | Aggiornamento | Societe Generale | Hold → Buy |
| 2021-01-22 | Downgrade | Societe Generale | Hold → Sell |
| 2020-11-02 | Aggiornamento | Societe Generale | Sell → Hold |
| 2020-08-06 | Downgrade | Societe Generale | Buy → Sell |
| 2020-08-05 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-17 | Downgrade | Stifel | Buy → Hold |
| 2020-01-09 | Aggiornamento | Stifel | Hold → Buy |
| 2019-12-16 | Iniziato | Citigroup | Buy |
| 2019-09-05 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-06-17 | Iniziato | Goldman | Buy |
| 2018-12-20 | Downgrade | Barclays | Overweight → Equal Weight |
| 2018-12-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2018-12-20 | Downgrade | Jefferies | Buy → Hold |
| 2018-12-20 | Downgrade | Stifel | Buy → Hold |
| 2017-10-31 | Aggiornamento | Societe Generale | Sell → Hold |
| 2017-10-24 | Downgrade | Societe Generale | Buy → Sell |
| 2017-10-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2017-06-23 | Iniziato | Deutsche Bank | Buy |
| 2017-03-16 | Aggiornamento | Societe Generale | Hold → Buy |
| 2016-09-26 | Iniziato | JMP Securities | Mkt Outperform |
| 2015-12-03 | Iniziato | Barclays | Overweight |
| 2015-10-23 | Iniziato | BofA/Merrill | Buy |
Mostra tutto
Dbv Technologies Adr Borsa (DBVT) Ultime notizie
European ADRs Started The Week Higher In US Trading - Finimize
DBV Technologies (NASDAQ:DBVT) Shares Gap Up – Still a Buy? - Defense World
DBV Technologies Announces €166.7 Million in Gross Proceeds - GlobeNewswire
DBV Technologies annonce avoir reçu un produit brut de 166,7 millions d'euros suite à l'exercice intégral des Bons de Souscription (BS) issus des ABSAs et des BS issus des PFW-BS-PFW émis dans le cadre de son financement de mars 2025 - GlobeNewswire Inc.
European ADRs Slipped, But Biotech Names Still Stole The Show - Finimize
Worthington Steel, Immunitybio, Riot Platforms, Micron Technology And Other Big Stocks Moving Higher On Friday - Benzinga
€166.7M fuels DBV plan to launch peanut allergy skin patch for kids - Stock Titan
DBV Technologies S.A. (NASDAQ:DBVT) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading - MSN
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF - The Manila Times
European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading - MSN
The Insider Report: A Tape Fitting for the Holiday - Sahm
European ADRs Started The Week Higher, Led By Biotech - Finimize
Sidus Space, Starfighters Space And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Honeywell, Intuitive Machines And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Sahm
DBV Technologies (NASDAQ:DBVT) Shares Gap Down on Insider Selling - Defense World
H.C Wainwright and Citizens Raise PT on DBV Technologies (DBVT) Following Phase 3 VITESSE Trial Result - Finviz
Stock Market Today 21.12.2025 - ts2.tech
HC Wainwright Boosts Earnings Estimates for DBV Technologies - Defense World
DBV Technologies (NASDAQ:DBVT) Given New $45.00 Price Target at Citizens Jmp - Defense World
DBV Technologies S.A. (NASDAQ:DBVT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
HC Wainwright Has Positive Outlook for DBVT FY2026 Earnings - Defense World
European Stocks On Wall Street Delivered Modest Moves For Investors - Finimize
Birkenstock, Insmed And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
DBV Technologies (NASDAQ:DBVT) Sets New 12-Month High on Analyst Upgrade - Defense World
Crude Oil Rises Over 1%; General Mills Earnings Top Views - Benzinga
Toro, DBV Technologies, Udemy, ABM Industries And Other Big Stocks Moving Higher On Wednesday - Benzinga
Citizens raises DBV Technologies stock price target to $45 on Viaskin Peanut success By Investing.com - ca.investing.com
Pre Market Movers: DBVT, YCBD, KYTX Set The Pace - RTTNews
Citizens raises DBV Technologies stock price target to $45 on Viaskin Peanut success - Investing.com UK
DBV Technologies receive positive results in key study with peanut patch - medwatch.com
Why Aditxt Shares Are Trading Higher By Around 63%; Here Are 20 Stocks Moving Premarket - Benzinga
Cantor Fitzgerald Upgrades DBV Technologies (NASDAQ:DBVT) to “Strong-Buy” - Defense World
DBV Technologies stock soars after positive Phase 3 trial results - Investing.com
DBV Technologies Reports Positive Phase 3 Trial Results - TipRanks
DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years - The Manila Times
DBV Technologies Announces Positive Topline Results from - GlobeNewswire
Peanut Allergy Patch For Kids? DBV Technologies Advances Toward FDA Filing - Sahm
DBV Technologies (NASDAQ:DBVT) Shares Gap DownTime to Sell? - MarketBeat
Micron Technology To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
This SiTime Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
DBV Technologies stock price target raised to $35 from $20 at H.C. Wainwright - Investing.com
DBV Technologies stock initiated with Overweight rating at Cantor Fitzgerald By Investing.com - Investing.com Nigeria
DBV Technologies stock initiated with Overweight rating at Cantor Fitzgerald - Investing.com
Dbv Technologies Adr Azioni (DBVT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Dbv Technologies Adr Azioni (DBVT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| EPIC Bpifrance | Member of 10% owner group |
Dec 18 '25 |
Sale |
4.19 |
1,292,103 |
5,413,912 |
7,303,369 |
| Mohideen Pharis | Chief Medical Officer |
Nov 20 '25 |
Sale |
2.88 |
6,496 |
18,708 |
103,153 |
| Mohideen Pharis | Chief Medical Officer |
Nov 21 '25 |
Sale |
2.77 |
1,624 |
4,498 |
101,529 |
| Mohideen Pharis | Chief Medical Officer |
Jul 29 '25 |
Sale |
2.22 |
464 |
1,030 |
109,649 |
| Mohideen Pharis | Chief Medical Officer |
May 22 '25 |
Sale |
1.84 |
397 |
730 |
110,113 |
| Mohideen Pharis | Chief Medical Officer |
Jan 30 '25 |
Sale |
0.85 |
600 |
510 |
110,510 |
2.09%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):